173 related articles for article (PubMed ID: 9069045)
1. Preliminary study of glycopyrrolate in the management of drooling.
Stern LM
J Paediatr Child Health; 1997 Feb; 33(1):52-4. PubMed ID: 9069045
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic medications for reducing drooling in children with developmental disability.
Reid SM; Westbury C; Guzys AT; Reddihough DS
Dev Med Child Neurol; 2020 Mar; 62(3):346-353. PubMed ID: 31495925
[TBL] [Abstract][Full Text] [Related]
3. Drooling Reduction Intervention randomised trial (DRI): comparing the efficacy and acceptability of hyoscine patches and glycopyrronium liquid on drooling in children with neurodisability.
Parr JR; Todhunter E; Pennington L; Stocken D; Cadwgan J; O'Hare AE; Tuffrey C; Williams J; Cole M; Colver AF
Arch Dis Child; 2018 Apr; 103(4):371-376. PubMed ID: 29192000
[TBL] [Abstract][Full Text] [Related]
4. Glycopyrrolate for chronic drooling in children.
Eiland LS
Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330
[TBL] [Abstract][Full Text] [Related]
5. Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience.
Zanon D; Tumminelli C; Galimberti AMC; Torelli L; Maestro A; Barbi E; Maximova N
Ital J Pediatr; 2021 Nov; 47(1):222. PubMed ID: 34742343
[TBL] [Abstract][Full Text] [Related]
6. Glycopyrrolate treatment of chronic drooling.
Blasco PA; Stansbury JC
Arch Pediatr Adolesc Med; 1996 Sep; 150(9):932-5. PubMed ID: 8790123
[TBL] [Abstract][Full Text] [Related]
7. The drooling reduction intervention trial (DRI): a single blind trial comparing the efficacy of glycopyrronium and hyoscine on drooling in children with neurodisability.
Parr JR; Weldon E; Pennington L; Steen N; Williams J; Fairhurst C; O'Hare A; Lodh R; Colver A
Trials; 2014 Feb; 15():60. PubMed ID: 24533890
[TBL] [Abstract][Full Text] [Related]
8. Glycopyrrolate for drooling in children with medical complexity under three years of age.
Lovardi E; De Ioris MA; Lettori D; Geremia C; Staccioli S; Bella GD; Scrocca R; Scarselli A; Aversa M; De Peppo F; Campana A; Castelli E
Ital J Pediatr; 2022 Jan; 48(1):2. PubMed ID: 34998418
[TBL] [Abstract][Full Text] [Related]
9. Treatment of sialorrhea with glycopyrrolate: A double-blind, dose-ranging study.
Mier RJ; Bachrach SJ; Lakin RC; Barker T; Childs J; Moran M
Arch Pediatr Adolesc Med; 2000 Dec; 154(12):1214-8. PubMed ID: 11115305
[TBL] [Abstract][Full Text] [Related]
10. A systematic review for evidence of efficacy of anticholinergic drugs to treat drooling.
Jongerius PH; van Tiel P; van Limbeek J; Gabreëls FJ; Rotteveel JJ
Arch Dis Child; 2003 Oct; 88(10):911-4. PubMed ID: 14500313
[TBL] [Abstract][Full Text] [Related]
11. Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults.
Blissit KT; Tillery E; Latham C; Pacheco-Perez J
Am J Health Syst Pharm; 2014 Aug; 71(15):1282-7. PubMed ID: 25027535
[TBL] [Abstract][Full Text] [Related]
12. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy.
Bachrach SJ; Walter RS; Trzcinski K
Clin Pediatr (Phila); 1998 Aug; 37(8):485-90. PubMed ID: 9729704
[TBL] [Abstract][Full Text] [Related]
13. Glycopyrrolate oral solution: for chronic, severe drooling in pediatric patients with neurologic conditions.
Garnock-Jones KP
Paediatr Drugs; 2012 Aug; 14(4):263-9. PubMed ID: 22646067
[TBL] [Abstract][Full Text] [Related]
14. Glycopyrrolate treatment of drooling in an adult male patient with cerebral palsy.
Neverlien PO; Sorumshagen L; Eriksen T; Grinna T; Kvalshaugen H; Lind AB
Clin Exp Pharmacol Physiol; 2000 Apr; 27(4):320-2. PubMed ID: 10779132
[TBL] [Abstract][Full Text] [Related]
15. In brief: Glycopyrrolate oral solution for sialorrhea.
Med Lett Drugs Ther; 2011 Jan; 53(1355):4. PubMed ID: 21212745
[No Abstract] [Full Text] [Related]
16. Glycopyrronium for severe drooling in children.
Drug Ther Bull; 2017 Aug; 55(8):93-96. PubMed ID: 28808084
[TBL] [Abstract][Full Text] [Related]
17. Oral glycopyrrolate alleviates drooling in a patient with tongue cancer.
Olsen AK; Sjøgren P
J Pain Symptom Manage; 1999 Oct; 18(4):300-2. PubMed ID: 10534970
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study.
Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT
Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191
[TBL] [Abstract][Full Text] [Related]
19. Management of drooling in children: a survey of UK paediatricians' clinical practice.
Parr JR; Buswell CA; Banerjee K; Fairhurst C; Williams J; O'Hare A; Pennington L;
Child Care Health Dev; 2012 Mar; 38(2):287-91. PubMed ID: 21392056
[TBL] [Abstract][Full Text] [Related]
20. Sialorrhea - therapeutic drug options.
Tscheng DZ
Ann Pharmacother; 2002 Nov; 36(11):1785-90. PubMed ID: 12398577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
